Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-08-13 to 2025-08-13
Current total value of award: $377.1
Description: 4569078017!ARTIFICIAL TEARS SOLU